Proteostasis

PTI NASDAQ
0.6615
+0.0315
+5.00%
盘后: 0.6615 0 0.00% 17:00 08/16 EDT
开盘
0.6457
昨收
0.6300
最高
0.6800
最低
0.6302
成交量
64.91万
成交均量(3M)
98.13万
52周最高
10.38
52周最低
0.6100
换手率
1.27%
市值
3,382.18万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Proteostasis PTI股票价格,Proteostasis股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. The Company focuses on identifying therapies that restore protein function. The Company’s CF focused pipeline consists of novel CFTR modulators including correctors, potentiators and amplifiers. The Company’s clinical developments include PTI-801, a third generation CFTR corrector, PTI-808, a CFTR potentiator, and PTI-428, a CFTR amplifier.
展开 >

最近浏览

名称
价格
涨跌幅